Cover Image

Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold

An efficient synthesis of substituted pyrido[2,3-d]pyrimidines was carried out and evaluated for in vitro anticancer activity against five cancer cell lines, namely hepatic cancer (HepG-2), prostate cancer (PC-3), colon cancer (HCT-116), breast cancer (MCF-7), and lung cancer (A-549) cell lines. Reg...

Full description

Saved in:

Bibliographic Details
Main Authors:	Heba S. A. Elzahabi (Author), Eman S. Nossier (Author), Nagy M. Khalifa (Author), Rania A. Alasfoury (Author), May A. El-Manawaty (Author)
Format:	Book
Published:	Taylor & Francis Group, 2018-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers
by: Heba S. A. Elzahabi, et al.
Published: (2022)

Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
by: Eman Z. Elrazaz, et al.
Published: (2015)

Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
by: Marwa A. Aziz, et al.
Published: (2016)

Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
by: Nasser S.M. Ismail, et al.
Published: (2016)

Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors
by: Jianfang Fu, et al.
Published: (2023)

Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
by: Nasser S.M. Ismail, et al.
Published: (2016)

Identification of Novel Cyanopyridones and Pyrido[2,3-<em>d</em>]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies
by: Tarfah Al-Warhi, et al.
Published: (2022)

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
by: Ashwag S. Alanazi, et al.
Published: (2023)

Discovery of New Pyrrolo[2,3-<i>d</i>]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers
by: AbdulAziz A. Alotaibi, et al.
Published: (2023)

Synthesis and cytotoxic evaluation of some novel 3-[2-(2-phenyl-thiazol-4-yl)-ethyl] -3H-pyrido [2,3-d]pyrimidin-4-one derivatives
by: Marzieh Rahmani Khajouei, et al.
Published: (2021)

Expanding the Diversity at the C-4 Position of Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones to Achieve Biological Activity against ZAP-70
by: Victor Masip, et al.
Published: (2021)

Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents
by: Rania S.M. Ismail, et al.
Published: (2016)

Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M
by: Ahmed A. Gaber, et al.
Published: (2022)

Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-<i>d</i>], [3,2-<i>d</i>], [3,4-<i>d</i>] and [4,3-<i>d</i>]pyrimidine Derivatives
by: Joana F. Campos, et al.
Published: (2022)

Microwave-Assisted Synthesis of Potential Bioactive Benzo-, Pyrido- or Pyrazino-thieno[3,2-<i>d</i>]pyrimidin-4-amine Analogs of MPC-6827
by: Yvonnick Loidreau, et al.
Published: (2020)

Anticancer Activity Evaluation of New Thieno[2,3-d]pyrimidin-4(3H)-ones and Thieno[3,2-d]pyrimidin-4(3H)-one Derivatives
by: Olga Shyyka, et al.
Published: (2018)

Design, synthesis, docking, and anticancer evaluations of new thiazolo[3,2-a] pyrimidines as topoisomerase II inhibitors
by: Mona S. El-Zoghbi, et al.
Published: (2023)

Pyrimidine: a review on anticancer activity with key emphasis on SAR
by: Aastha Mahapatra, et al.
Published: (2021)

New Quinazolin-4(3<i>H</i>)-one Derivatives Incorporating Hydrazone and Pyrazole Scaffolds as Antimicrobial Agents Targeting DNA Gyraze Enzyme
by: Eman M. Mohi El-Deen, et al.
Published: (2022)

Nucleoside cyclic 3',5'-phosphorothioates with purine and pyrimidine scaffolds. A chemical minireview
by: Kjell Undheim
Published: (2022)

Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors
by: Eman A. Sobh, et al.
Published: (2023)

Pyrido[2',1':2,3]imidazo[4,5-<i>c</i>]isoquinolin-5-amines as Potential Cytotoxic Agents against Human Neuroblastoma
by: Zahira Tber, et al.
Published: (2021)

Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening
by: Marie Hoarau, et al.
Published: (2021)

Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
by: Sonali Kurup, et al.
Published: (2018)

Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells
by: Alexander M. Scherbakov, et al.
Published: (2018)

N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output
by: Igor V. Ukrainets, et al.
Published: (2018)

The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl<sub>4</sub>-Induced Liver Fibrosis in Rats
by: Diana K. Ghobrial, et al.
Published: (2023)

New Pyrazole/Pyrimidine-Based Scaffolds as Inhibitors of Heat Shock Protein 90 Endowed with Apoptotic Anti-Breast Cancer Activity
by: Lamya H. Al-Wahaibi, et al.
Published: (2024)

Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug resistant Mycobacterium tuberculosis
by: Loah R. Hemeda, et al.
Published: (2023)

Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor
by: Karsten Niefind, et al.
Published: (2017)

Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
by: Asmaa A. Mandour, et al.
Published: (2022)

Medicinal attributes of pyridine scaffold as anticancer targeting agents
by: Esraa Ali Mohamed, et al.
Published: (2021)

Pyrrole as an Important Scaffold of Anticancer Drugs: Recent Advances
by: Emilio Mateev, et al.
Published: (2022)

Recent Advances in Pyrimidine-Based Drugs
by: Baskar Nammalwar, et al.
Published: (2024)

Inhibition of protein kinases by anticancer DNA intercalator, 4-butylaminopyrimido[4',5':4,5]thieno(2,3-b)quinoline
by: HeggoduG. Rohit Kumar, et al.
Published: (2017)

Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect
by: Hany E. A. Ahmed, et al.
Published: (2018)

Sphingosine kinase 1 as an anticancer therapeutic target
by: Gao Y, et al.
Published: (2015)

Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma
by: Naglaa Mohamed Ahmed, et al.
Published: (2019)

The Synthesis, Antimicrobial Activity, and Molecular Docking of New 1, 2, 4-Triazole, 1, 2, 4-Triazepine, Quinoline, and Pyrimidine Scaffolds Condensed to Naturally Occurring Furochromones
by: Ameen Ali Abu-Hashem, et al.
Published: (2022)

Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study
by: Fatma M. Elmenier, et al.
Published: (2022)